CBS 2019
CBSMD教育中心
English

DAPT Duration

科研文章

荐读文献

Individualized antiplatelet therapy after drug-eluting stent deployment: Implication of clinical trials of different durations of dual antiplatelet therapy Ticagrelor With or Without Aspirin After Complex PCI Osteoarthritis risk is reduced after treatment with ticagrelor compared to clopidogrel: a propensity score matching analysis Ticagrelor vs Clopidogrel After Fibrinolytic Therapy in Patients With ST-Elevation Myocardial Infarction: A Randomized Clinical Trial P2Y12 Inhibitor Monotherapy with Clopidogrel Versus Ticagrelor in Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention Dual antiplatelet therapy: how, how long, and in which patients? Clopidogrel Pharmacogenetics: State-of-the-Art Review and the TAILOR-PCI Study A new strategy for discontinuation of dual antiplatelet therapy: the RESET Trial (REal Safety and Efficacy of 3-month dual antiplatelet Therapy following Endeavor zotarolimus-eluting stent implantation) Ticagrelor With or Without Aspirin After PCI: The TWILIGHT Platelet Substudy Outcomes in patients treated with ticagrelor or clopidogrel after acute myocardial infarction: experiences from SWEDEHEART registry

Clinical TrialVolume 7, Issue 1, January 2014

JOURNAL:JACC: Cardiovascular Imaging Article Link

Impact of Positive and Negative Lesion Site Remodeling on Clinical Outcomes : Insights From PROSPECT

Inaba S, Mintz GS, Maehara A et al. Keywords: CSA; DC; EEM; FF; FT; IVUS; MLA; NC; NCL MACE; RI; ROC; TCFA; ThCFA; VH; cardiovascular events; cross-sectional; dense calcium; external elastic membrane; fibrofatty; fibrotic; intravascular ultrasound; minimal lumen area; necrotic core; nonculprit lesion major adverse cardiac event(s); receiver-operating characteristic; remodeling; remodeling index; thick-cap fibroatheroma; thin-cap fibroatheroma; virtual histology

FULL TEXT PDF